Location History:
- San Francisco, CA (US) (1986 - 1987)
- Milton, MA (US) (1989)
- Allison Park, PA (US) (1995 - 1996)
- Wexford, PA (US) (1990 - 1997)
- Orlando, FL (US) (1996 - 2013)
- Ft. Lauderdale, FL (US) (2018 - 2021)
- Fort Lauderdale, FL (US) (2022 - 2023)
Company Filing History:
6 out of 6 
4 out of 15 
2 out of 37 
Years Active: 1986-2025
Title: Innovations of Gary M. Onik in Cancer Treatment
Introduction:
Gary M. Onik, based in Fort Lauderdale, Florida, is a notable inventor with an impressive portfolio of 20 patents. His work primarily focuses on advanced medical technologies, particularly in the realm of cancer treatment. Onik's innovative approaches have the potential to revolutionize how we understand and combat cancer, integrating both immunotherapy and advanced ablation techniques.
Latest Patents:
Among Gary M. Onik's recent patents is a groundbreaking method for cancer immunotherapy through radiofrequency electrical membrane breakdown (RF-EMB). This approach involves non-thermally ablating undesirable tissues by utilizing pulsed, bipolar, instant charge reversal electrical fields. The process effectively causes complete cell membrane rupture and destruction, delivering energy through radio frequency pulses that stress the cell membrane, enabling a robust immunological response to eliminate targeted tissues.
Another of his latest inventions focuses on the immunologic treatment of cancer. This patent discusses new compositions, methods, and devices for cancer treatment that combine immunologic chemotherapeutic agents with ablation techniques. The innovations include immune checkpoint inhibitors, cytokines, and nucleic acid drugs, all aimed at provoking an immune response to target tumors. The strategic administration of these compositions, along with various ablative techniques, presents tumor antigens to the immune system for more effective immunologic targeting.
Career Highlights:
Gary M. Onik's career is marked by groundbreaking contributions to medical science. Over the years, he has developed a strong implementation of his inventions in clinical settings, significantly impacting cancer treatment methodologies. His 20 patents reflect not only his inventive spirit but also his commitment to advancing healthcare through technology.
Collaborations:
Throughout his career, Gary has collaborated with several esteemed professionals in the field, including James A. Miessau and Boris Rubinsky. These partnerships have facilitated the development and refinement of his technologies, fostering an environment of innovation and shared expertise.
Conclusion:
Gary M. Onik stands as a pivotal figure in the domain of cancer treatment, with his inventive methodologies promising to change the landscape of oncological therapies. His latest patents exemplify a fusion of science and technology designed to enhance patient outcomes and further our understanding of immunotherapy. As the field evolves, the contributions of inventors like Onik will be critical in the ongoing fight against cancer.